Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,023,444 papers from all fields of science
Search
Sign In
Create Free Account
AH 1058
Known as:
AH-1058
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Bridged Bicyclo Compounds
Piperidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
AH-1058: a novel cardioselective Ca2+ channel blocker.
A. Takahara
,
A. Sugiyama
,
R. Yoshimoto
,
K. Hashimoto
Cardiovascular Drug Reviews
2006
Corpus ID: 251754
The pharmacologic profile of a cyproheptadine-related compound, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[(E)-3-(3-methoxy-2…
Expand
2001
2001
Utilization of telemetry system to assess the cardiovascular profile of AH-1058, a new cardioselective Ca2+ channel blocker, in conscious dogs.
Akira Takahara
,
H. Dohmoto
,
Ryota Yoshimoto
,
Atsushi Sugiyama
,
Keitaro Hashimoto
Japanese Journal of Pharmacology
2001
Corpus ID: 33235551
Cardiovascular effects of a new Ca2+ channel blocker AH-1058, 4-(5H-dibenzo[a,d]cyclo-hepten-5-ylidene)-1-[(E)-3-(3-methoxy-2…
Expand
2001
2001
Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
A. Takahara
,
H. Dohmoto
,
R. Yoshimoto
,
A. Sugiyama
,
K. Hashimoto
European Journal of Pharmacology
2001
Corpus ID: 30434076
2000
2000
Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model.
A. Takahara
,
A. Sugiyama
,
H. Dohmoto
,
R. Yoshimoto
,
K. Hashimoto
Japanese Journal of Pharmacology
2000
Corpus ID: 40204237
AH-1058 (4-(5H-dibenzo[a, d]cyclohepten-5-ylidene)- 1-[(E)-3-(3-methoxy-2-nitro)phenyl-2-propenyl]piperidine hydrochloride) is a…
Expand
2000
2000
Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
A. Takahara
,
A. Sugiyama
,
H. Dohmoto
,
R. Yoshimoto
,
K. Hashimoto
Journal of Cardiovascular Pharmacology
2000
Corpus ID: 20543461
The cardiovascular effects of AH-1058, a novel calcium channel blocker, were examined in comparison with those of verapamil using…
Expand
2000
2000
Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.
Akira Takahara
,
Atsushi Sugiyama
,
H. Dohmoto
,
R. Yoshimoto
,
Keitaro Hashimoto
European Journal of Pharmacology
2000
Corpus ID: 43043098
1999
1999
Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
A. Takahara
,
H. Uneyama
,
+6 authors
R. Yoshimoto
Journal of Cardiovascular Pharmacology
1999
Corpus ID: 45140980
AH-1058 is a newly synthesized antiarrhythmic agent. We investigated the antiarrhythmic and electrophysiological effects of AH…
Expand
1999
1999
Calcium channel antagonistic effects of AH-1058, a novel antiarrhythmic drug, on guinea-pig myocardium.
H. Tanaka
,
T. Ichikawa
,
+4 authors
K. Shigenobu
Research Communications in Molecular Pathology…
1999
Corpus ID: 37282734
Effects of AH-1058, a novel cyproheptadine derivative with high antiarrhythmic activity in in vivo arrhythmia models, were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE